Related references
Note: Only part of the references are listed.Induction of hypoxia-inducible factor-1α by BDNF protects retinoblastoma cells against chemotherapy-induced apoptosis
Yu Gao et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2016)
The Role of Cytokines in Breast Cancer Development and Progression
Marcela Esquivel-Velazquez et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2015)
Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
Yingqian Lv et al.
ONCOTARGETS AND THERAPY (2015)
Triple-negative breast cancer: new perspectives for targeted therapies
Federica Tomao et al.
ONCOTARGETS AND THERAPY (2015)
HIF-1α pathway: role, regulation and intervention for cancer therapy
Georgina N. Masoud et al.
ACTA PHARMACEUTICA SINICA B (2015)
HIF-1 Signaling in Drug Resistance to Chemotherapy
N. A. Warfel et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Retraction Note to: IL-6 secreted by cancer-associated fibroblasts induces tamoxifen resistance in luminal breast cancer
X Sun et al.
ONCOGENE (2014)
Systemic treatment strategies for triple-negative breast cancer
Budhi Singh Yadav et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2014)
The role of intratumoral and systemic IL-6 in breast cancer
Christine Dethlefsen et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells
Yun-Jeong Jeong et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Distant metastasis in triple-negative breast cancer
L. M. Tseng et al.
NEOPLASMA (2013)
Mesenchymal stem cells in the tumor microenvironment (Review)
Jian Guan et al.
BIOMEDICAL REPORTS (2013)
Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
Zhi Shi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Current management and treatment strategies for breast cancer
John H. Howard et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2012)
IL6-STAT3-HIF Signaling and Therapeutic Response to the Angiogenesis Inhibitor Sunitinib in Ovarian Clear Cell Cancer
Michael S. Anglesio et al.
CLINICAL CANCER RESEARCH (2011)
Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells
Yue Wang et al.
CANCER LETTERS (2010)
Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia
Lionel Flamant et al.
MOLECULAR CANCER (2010)
Triple-negative breast cancer: Present challenges and new perspectives
Franca Podo et al.
MOLECULAR ONCOLOGY (2010)
Autocrine IL-6 signaling: A key event in tumorigenesis?
Sergei Grivennikov et al.
CANCER CELL (2008)
Hypoxia-inducible factor-1 (HIF-1)
Qingdong Ke et al.
MOLECULAR PHARMACOLOGY (2006)
Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance
JT Erler et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis
AE Greijer et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation
CJ Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
